Evolus, Inc. (EOLS) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Evolus, Inc. Common Stock.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.334 Good afternoon, everyone, and thank you for standing by. 00:00:02.334 -- 00:00:07.562 Welcome to Evelus's fourth quarter and full year 2025 earnings conference 00:00:07.562 -- 00:00:09.064 call. 00:00:09.064 -- 00:00:12.329 At this time, all participants are in a listen-only mode. 00:00:12.329 -- 00:00:15.072 A question and answer session will follow the formal presentation. 00:00:15.072 -- 00:00:17.072 As 00:00:17.416 -- 00:00:21.201 a reminder, today's conference call is being recorded in webcast live. 00:00:21.201 -- 00:00:23.925 All participants are in a listen-only mode, and after the speaker's remarks, there will 00:00:23.925 -- 00:00:27.791 be a question and answer session. I'd like to turn the conference call over to Narek 00:00:27.791 -- 00:00:32.338 Zagarian, Vice President and Head of Global Investor Relations and Corporate Communications. 00:00:32.338 -- 00:00:34.719 Please go ahead. 00:00:35.162 -- 00:00:39.808 Thank you, Operator, and welcome to everyone joining us on today's call to review Evelus' 00:00:39.808 -- 00:00:44.174 fourth quarter and full year 2025 financial results. 00:00:44.174 -- 00:00:50.863 Our fourth quarter and full year 2025 press release is now on our website at evelus.com. 00:00:50.863 -- 00:00:55.970 With me today are David Modazzetti, President and Chief Executive Officer, and Tatiana 00:00:55.970 -- 00:01:01.629 Mitchell, Chief Financial Officer. Rui Avalar, Chief Medical Officer and Head of R&D 00:01:01.629 -- 00:01:05.414 is also with us for the Q&A portion of the call. 00:01:05.414 -- 00:01:08.478 Today's call will include forward-looking statements. 00:01:08.478 -- 00:01:13.284 Actual results may differ materially due to risks and uncertainties outlined in our earnings 00:01:13.284 -- 00:0...